Xinxiang Tuoxin Pharmaceutical Co.Ltd. Cash Flow Reinvestment Rate
Xinxiang Tuoxin Pharmaceutical Co.Ltd. cash flow reinvestment rate. Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Cash Flow Reinvestment Rate of 1.37x as of December 2024, reinvesting CN¥140.48 Million (capex CN¥83.91 Million plus investments CN¥-56.57 Million) from operating cash flow of CN¥102.67 Million. See Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2024)
Cash flow reinvestment rate of Xinxiang Tuoxin Pharmaceutical Co.Ltd. from 2019 to 2024. Historical reinvestment intensity for Xinxiang Tuoxin Pharmaceutical Co.Ltd. across 6 annual periods. Explore Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Cash Flow Reinvestment Rate by Year (2019–2024)
Xinxiang Tuoxin Pharmaceutical Co.Ltd. cash flow reinvestment rate by year from 2019 to 2024. Year-by-year capital reinvestment analysis for Xinxiang Tuoxin Pharmaceutical Co.Ltd.. For the full cash flow conversion analysis, see 301089 cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.37x | CN¥140.48 Million | CN¥102.67 Million | CN¥83.91 Million | ▼ -84.7% |
| 2023 | 8.97x | CN¥241.79 Million | CN¥26.95 Million | CN¥185.22 Million | ▲ +676.1% |
| 2022 | 1.16x | CN¥310.74 Million | CN¥268.85 Million | CN¥148.33 Million | ▼ -84.6% |
| 2021 | 7.48x | CN¥435.46 Million | CN¥58.19 Million | CN¥112.73 Million | ▲ +508.7% |
| 2020 | 1.23x | CN¥147.51 Million | CN¥120.00 Million | CN¥74.12 Million | ▼ -32.1% |
| 2019 | 1.81x | CN¥156.36 Million | CN¥86.38 Million | CN¥76.20 Million | — |